Epigenomics AG, a biotech company specializing in liquid biopsy tests for cancer detection, faces financial instability and a critical juncture in its journey to fulfill its pioneering potential.

Epigenomics AG is a biotechnology company pioneering the development of liquid biopsy tests for cancer diagnostics, aiming to improve patient outcomes and make a global impact in the fight against cancer.